Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Infectious diseases, microbiology and sexual health indexChapter sections
Role and principlesAssessment and patient selectionBaseline assessmentInterventionsTargets, monitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook9 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Notifiable diseases and public-health action

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Notify the proper officer or local UKHSA health-protection team urgently when a notifiable disease is suspected; do not wait for confirmation. Use emergency infection-control and specialist pathways for meningococcal disease, measles, diphtheria, viral haemorrhagic fever, botulism and other immediately hazardous presentations.

Role and principles

Recognise when clinical suspicion triggers statutory notification, take immediate infection-control action and work with UKHSA health-protection teams without waiting for laboratory confirmation.

Notification converts an individual clinical suspicion into a population-protection assessment. The purpose is not surveillance alone: early contact management, vaccination, prophylaxis, food or water investigation and outbreak control may prevent further cases. The threshold is therefore suspicion of a listed disease, not diagnostic certainty.

The clinician stabilises and treats the patient, institutes transmission precautions and contacts the proper officer or health-protection team through the locally published route. Urgent diseases require same-day telephone communication. The public-health team then refines case definition, identifies contacts and coordinates wider action with laboratories, schools, workplaces or environmental services.

Confidentiality remains important but does not prohibit statutory notification. Share accurate relevant information, document the legal and clinical basis, and tell the patient when safe and practicable. Correct errors quickly because an incorrect diagnosis or contact detail can cause unnecessary exclusion or missed prophylaxis.

Key points

  • Registered medical practitioners in England have a statutory duty to notify the proper officer of specified suspected diseases; use the current UKHSA online service for every report and the local health-protection team for urgent cases.

Assessment and patient selection

Clinical suspicion is enoughRed flag

A compatible syndrome and exposure for a listed disease triggers notification even when molecular, culture or serology results are pending.

Immediate contact-management diseaseRed flag

Meningococcal disease, measles, diphtheria and several other infections may require rapid prophylaxis, vaccination, exclusion or specialist sampling of contacts.

Possible food or water clusterRed flag

Similar gastrointestinal illness among linked people, unusual organism or shared venue indicates environmental and outbreak action beyond individual treatment.

Laboratory-only signal

A laboratory may notify a causative organism independently, but this does not remove the clinician's duty to notify a suspected notifiable disease.

Baseline assessment

  1. 01
    Current statutory disease listFirst step
    Why
    Confirm that the suspected clinical diagnosis is notifiable and determine urgency.
    Interpretation and limitations
    Use current GOV.UK guidance rather than memory; the list and reporting arrangements can be updated.
  2. 02
    Local health-protection contact route
    Why
    Identify the proper officer or UKHSA team and after-hours mechanism.
    Interpretation and limitations
    Telephone urgent notifications and follow the requested secure written process; routine email to an unverified address risks delay and confidentiality breach.
  3. 03
    Case-defining clinical and exposure data
    Why
    Provide onset, symptoms, vaccination, travel, occupation, setting and plausible source.
    Interpretation and limitations
    Precise dates and locations allow the team to define infectious periods and contacts; uncertainty should be stated rather than filled with assumptions.
  4. 04
    Pathogen-specific specimens
    Why
    Support confirmation, typing and resistance or outbreak linkage.
    Interpretation and limitations
    Discuss unusual or hazardous organisms with the reference laboratory before sampling; treatment and notification must not wait when the syndrome is time critical.
  5. 05
    Contact and setting assessment

Interventions

01Suspected notifiable diseaseNotify while treatingFirst stepClinical features and epidemiology make a listed disease plausible.+
  1. 1Stabilise and treat the patient, apply pathogen-appropriate precautions and check the current statutory notification guidance.
  2. 2For a disease in the urgent category, telephone the local health-protection team as soon as possible and within 24 hours; submit every notification through the online service within 3 days with accurate identifiers, onset, setting, exposures and clinical status.
  3. 3Collect advised specimens without delaying care, document notification and responsible contacts and follow instructions on contact management and transfer.
02Possible outbreakCreate an early shared pictureLinked cases, common exposure or unusual organism suggests an event affecting more than one person.+
  1. 1Inform infection prevention and health protection, preserve specimens and construct a confidential person-place-time line list with a working case definition.

Targets, monitoring and follow-up

  • Record time, method, recipient and content of notification, plus any reference number and named clinician responsible for follow-up.
  • Track confirmatory laboratory results and communicate material changes to the health-protection team immediately.
  • Maintain a secure contact and exposure log when requested, with clear definitions and the minimum necessary personal information.
  • Review isolation, exclusion, prophylaxis and vaccination actions against the infectious period and updated case classification.
  • Provide the patient with a clear route for questions and document public-health advice in discharge and primary-care communication.

Special situations

Notify suspicion, not certainty

The public-health value often lies in beginning contact action before confirmation; diagnostic uncertainty should be communicated rather than used as a reason for silence.

Laboratory reporting is separate

A positive laboratory notification does not retrospectively fulfil the registered medical practitioner's clinical notification duty.

The list is jurisdiction specific

England, Wales, Scotland and Northern Ireland have different legislation and operational routes. The pathway described is the England framework; clinicians must use the statutory arrangements for their jurisdiction.

Contact is a defined term

Proximity alone does not determine prophylaxis; exposure type, infectious period and pathogen-specific definitions guide health-protection decisions.

Common pitfalls

  1. 01

    Waiting for PCR or culture before notifying a clinically suspected listed disease.

  2. 02

    Assuming someone else or the laboratory has completed the notification.

  3. 03

    Sending identifiable information through an unverified insecure route.

  4. 04

    Promising prophylaxis to contacts before health-protection assessment.

  5. 05

    Failing to update the notified diagnosis when later evidence changes it.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Infectious diseases, microbiology and sexual healthOriginal SBA

Notification threshold

A doctor suspects measles from fever, rash, cough and a compatible exposure, but PCR will not be available until tomorrow. What is the correct action?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Infectious diseases, microbiology and sexual health topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UKHSA notifiable diseases and reporting guidanceCurrent England lists, suspicion threshold, urgent telephone categories and three-day online reporting route.
  • Health Protection Notification Regulations 2010Legal basis for registered practitioner and laboratory notifications in England.
  • GMC confidentiality and public protectionProfessional standards for proportionate information sharing and documentation.
  • UKHSA health protection teamsCurrent local health-protection team finder and urgent contact route.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
  • Notification is based on clinical suspicion when the disease is notifiable; laboratory confirmation and laboratory reporting are separate processes.
  • Urgent diseases must be telephoned to the health-protection team as soon as possible and within 24 hours; submit all notifications through the online service within 3 days. Routine notifications do not all require an urgent telephone call.
  • Immediate clinical care and isolation proceed in parallel with notification; completing a form must not delay resuscitation, antimicrobials or post-exposure action.
  • Check the current UKHSA list and urgency category at the point of care because diseases, reporting routes and categories can change; do not rely on an old paper list.
  • Explain information sharing honestly: public-health disclosure is lawful and proportionate for protection, while unrelated confidential information remains safeguarded.
    • Why
    Identify household, healthcare, educational, occupational or travel exposures.
    Interpretation and limitations
    The health-protection team determines who meets a formal contact definition; clinicians should not promise prophylaxis to every person who is worried.
  • 2Implement proportionate immediate controls for food, water, environment, exclusion or transmission while the investigation refines source and risk.
  • 3Coordinate consistent patient and public communication, update the line list and record when control criteria are met.
    • 03Result changes diagnosisCorrect the public-health recordLaboratory or specialist review weakens or changes the initially notified diagnosis.+
    1. 1Inform the health-protection team promptly with the new evidence rather than assuming laboratory systems will reconcile the case.
    2. 2Review isolation, contact and prophylaxis decisions with the team and communicate changed advice sensitively to the patient and affected contacts.
    3. 3Document the revised diagnosis and retain learning about why early notification was still appropriate at the original level of suspicion.